# Traceability - Tests

**Reconciled:** 2026-09-28

> ## Status: **NO TEST ARTIFACT EXISTS IN THE DOCUMENTATION CORPUS**
>
> No test matrix, no coverage requirement, no test ID namespace and no CI gate documentation
> exists under docs/WAPSELL-DOCUMENTATION/.
>
> **Scope note:** this axis covers the *documentation* corpus only. Test suites, if any, live in
> the application repositories and were **not** inspected — the mandate is documentation-only and
> no code was read or modified. So "no test artifact" means *no documented traceability to tests*,
> not *no tests exist*.

## Documented test requirements
**None.** No decision in the corpus maps to a test, and no spec states an acceptance criterion.

| Axis | Rows | Cells filled |
|---|---|---|
| Decision → Test | 18 (D-001…D-018) | **0** |
| DEC-001 direction → Test | 8 | **0** |

## Consequences
- The 00-WAPSELL-SPEC-GENERAL.md §13 claim that inventory integrity "está protegida en base de
  datos, aplicación y tests, con operaciones críticas transaccionales" is a **PROPOSED** statement
  with **no** test to point at. It must not be read as evidence of coverage.
- CON-007 / CON-019 record that SRC-007 §1 and §15 Inc-1 define quality rules whose scope is
  **NOT DETERMINABLE**; D-010 is undeterminable. So the quality rules that would generate tests
  are themselves unknown.

## Open
- No test traceability is possible from documentation. **OPEN.**
- See 00-GOVERNANCE/GOVERNANCE-RECONCILIATION-REPORT.md §5 (gap 5).